Related Experiment Videos

Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus

T G Geary1, S C Nulf, S J Alexander-Bowman

  • 1Animal Health Discovery Research, Pharmacia & Upjohn, Kalamazoo, Michigan 49007, USA.

Insights

Benzimidazole anthelmintics target beta-tubulin but are ineffective against adult filariae. Research suggests filarial beta-tubulin is not inherently resistant, opening avenues for new vaccines.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Drug Discovery

Background:

  • Benzimidazole anthelmintics target beta-tubulin, but their efficacy against adult filariae is limited.
  • Beta-tubulin is a potential target for antibody-based toxicity in filarial parasites.
  • Understanding beta-tubulin's role is crucial for developing effective filarial treatments and vaccines.

Purpose of the Study:

  • To clone and characterize beta-tubulin cDNAs from Dirofilaria immitis and Onchocerca volvulus.
  • To investigate the reasons behind benzimidazole insensitivity in adult filariae.
  • To assess the potential of beta-tubulin epitopes as antigens for a broad-spectrum filarial vaccine.

Main Methods:

  • Cloning and characterization of beta-tubulin cDNAs from Dirofilaria immitis and Onchocerca volvulus.
  • Genomic locus analysis of Onchocerca volvulus beta-tubulin.
  • Comparison of beta-tubulin sequences and genomic organization across different filarial species.

Main Results:

  • Filarial beta-tubulin proteins are highly similar to each other but distinct from some previously reported sequences.
  • Genomic organization comparisons suggest a potential misclassification of a previously reported beta-tubulin gene.
  • All analyzed filarial beta-tubulins encode phenylalanine at position 200, a site not associated with benzimidazole resistance.
  • The COOH-terminal region of filarial beta-tubulins is conserved and recognized by a lethal monoclonal antibody.

Conclusions:

  • Filarial beta-tubulin is likely not inherently insensitive to benzimidazoles.
  • The COOH-terminal region of beta-tubulin presents a conserved target for antibody-based therapies.
  • Beta-tubulin epitopes hold promise for developing a broad-spectrum filarial vaccine.

Related Concept Videos